Tobramycin Inhalation Solution

FDA Drug Profile — Tobramycin Inhalation Solution

Drug Details

Generic Name
Tobramycin Inhalation Solution
Brand Names
Tobramycin Inhalation Solution
Application Number
ANDA207080
Sponsor
Dr. Reddy's Laboratories Inc.
NDC Codes
1
Dosage Forms
INHALANT
Routes
RESPIRATORY (INHALATION)
Active Ingredients
TOBRAMYCIN

Indications and Usage

1 INDICATIONS AND USAGE Tobramycin inhalation solution is indicated for the management of cystic fibrosis in adults and pediatric patients 6 years of age and older with Pseudomonas aeruginosa. Safety and efficacy have not been demonstrated in patients under the age of 6 years, patients with forced expiratory volume in 1 second (FEV 1 ) <25% or >75% predicted, or patients colonized with Burkholderia cepacia [see Clinical Studies ( 14 ) ]. Tobramycin inhalation solution is an aminoglycoside antibacterial indicated for the management of cystic fibrosis in adults and pediatric patients 6 years of age and older with Pseudomonas aeruginosa . ( 1 ) Safety and efficacy have not been demonstrated in patients under the age of 6 years, patients with forced expiratory volume in 1 second (FEV 1 ) <25% or >75% predicted, or patients colonized with Burkholderia cepacia. ( 1 )